Literature DB >> 8356071

The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.

G M Twamley-Stein1, R Pepperkok, W Ansorge, S A Courtneidge.   

Abstract

Three members of the Src family of protein tyrosine kinases Src, Fyn, and Yes associate with the activated platelet-derived growth factor (PDGF) receptor in vivo. This interaction requires the Src homology 2 (SH2) domain of the Src family member and causes activation of the intrinsic activity of the Src family kinases. We microinjected cells with DNA encoding catalytically inactive forms of the Src and Fyn proteins and examined their effects on PDGF-mediated signaling in vivo. Kinase-inactive Src and Fyn inhibited PDGF-stimulated entry of cells into S phase, whereas kinase-active forms of the proteins had no inhibitory effects. An intact SH2 domain was required for inhibition. Furthermore, when kinase-inactive Fyn was comicroinjected with a plasmid expressing activated Ras, the cells could enter S phase, indicating that the expression of kinase-inactive Fyn did not damage cell viability. Injection of an antibody specific for Src, Fyn, and Yes also reduced signal transduction through the PDGF receptor but only when injected within 8 hr of PDGF stimulation. Together these results indicate that the ubiquitously expressed Src family members are required for PDGF-induced mitogenic signaling.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356071      PMCID: PMC47209          DOI: 10.1073/pnas.90.16.7696

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Association between the PDGF receptor and members of the src family of tyrosine kinases.

Authors:  R M Kypta; Y Goldberg; E T Ulug; S A Courtneidge
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

2.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.

Authors:  B J Mayer; P K Jackson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 3.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

4.  Binding of GAP to activated PDGF receptors.

Authors:  A Kazlauskas; C Ellis; T Pawson; J A Cooper
Journal:  Science       Date:  1990-03-30       Impact factor: 47.728

5.  Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.

Authors:  V Sorrentino; R Pepperkok; R L Davis; W Ansorge; L Philipson
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

6.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.

Authors:  M Hatakeyama; T Kono; N Kobayashi; A Kawahara; S D Levin; R M Perlmutter; T Taniguchi
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

Review 7.  Signal transduction by the receptors for platelet-derived growth factor.

Authors:  C H Heldin; B Westermark
Journal:  J Cell Sci       Date:  1990-06       Impact factor: 5.285

8.  PDGF induction of tyrosine phosphorylation of GTPase activating protein.

Authors:  C J Molloy; D P Bottaro; T P Fleming; M S Marshall; J B Gibbs; S A Aaronson
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

9.  Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.

Authors:  G Superti-Furga; S Fumagalli; M Koegl; S A Courtneidge; G Draetta
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

10.  Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions.

Authors:  N E Kremer; G D'Arcangelo; S M Thomas; M DeMarco; J S Brugge; S Halegoua
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  85 in total

1.  Ubiquitin-mediated degradation of active Src tyrosine kinase.

Authors:  K F Harris; I Shoji; E M Cooper; S Kumar; H Oda; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Src family kinases are required for integrin but not PDGFR signal transduction.

Authors:  R A Klinghoffer; C Sachsenmaier; J A Cooper; P Soriano
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.

Authors:  G Castoria; M V Barone; M Di Domenico; A Bilancio; D Ametrano; A Migliaccio; F Auricchio
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  RACK1 regulates G1/S progression by suppressing Src kinase activity.

Authors:  Vidya Mamidipudi; Jian Zhang; Kelly C Lee; Christine A Cartwright
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 5.  SRC: a century of science brought to the clinic.

Authors:  Alexey Aleshin; Richard S Finn
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

6.  The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts.

Authors:  D W Owens; G W McLean; A W Wyke; C Paraskeva; E K Parkinson; M C Frame; V G Brunton
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 7.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

8.  The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

Authors:  K Neet; T Hunter
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

9.  Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.

Authors:  M C Maa; T H Leu; D J McCarley; R C Schatzman; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 10.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.